MINDBIO THERAPEUTICS BEGINS DOSING MB22001 IN PHASE 2 CLINICAL TRIAL IN WORLD FIRST TAKE-HOME MICRODOSING STUDY IN PATIENTS WITH DEPRESSION World-first take-home approvals...
MINDBIO THERAPEUTICS BREAKTHROUGH DISCOVERY IN MICRODOSING CLINICAL TRIAL REVEALS SIGNIFICANT POSITIVE EFFECTS ON QUALITY OF SLEEPNew Discovery: MindBio's LSD-Microdosing Treatment Improves...
MINDBIO THERAPEUTICS CEO DEMONSTRATES HOW 1 MILLION MICRODOSES OF LSD CAN POTENTIALLY BE USED TO TREAT DEPRESSION 1 Million Microdoses used to create proprietary microdosing...
ETHICS APPROVAL FOR LANDMARK WORLD FIRST PHASE 2 CLINICAL TRIAL OF TAKE-HOME LSD-MICRODOSING FOR MAJOR DEPRESSIVE DISORDEREthics approval received for take-home LSD-Microdosing clinical...
PHASE 2 CLINICAL TRIAL HAS RECEIVED ETHICS APPROVAL FOR WORLD FIRST TAKE-HOME LSD-MICRODOSING TRIALS IN CANCER PATIENTS EXPERIENCING EMOTIONAL DISTRESSEthics approval granted The clinical trial...
MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants MindBio clinical trial...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.375 | -3.1914893617 | 11.75 | 11.75 | 11.25 | 817630 | 11.6137368 | DE |
4 | -1 | -8.08080808081 | 12.375 | 12.375 | 11.25 | 275102 | 11.67194942 | DE |
12 | -0.75 | -6.18556701031 | 12.125 | 13.25 | 11.25 | 291837 | 12.29216438 | DE |
26 | -0.875 | -7.14285714286 | 12.25 | 13.3 | 11.25 | 280553 | 12.39333126 | DE |
52 | -4.625 | -28.90625 | 16 | 16.1 | 11.25 | 337475 | 13.051939 | DE |
156 | 0.875 | 8.33333333333 | 10.5 | 20.3 | 10.5 | 269143 | 15.10336773 | DE |
260 | 0.875 | 8.33333333333 | 10.5 | 20.3 | 5.5 | 238350 | 13.7951253 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.